The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study
We confirm the prognostic relevance of 1q+ and TP53 loss in stage IV WTs and emphasize their potential utility for future treatment stratification.
Authors
- Norbert M. Graf (ORCID: https://orcid.org/0000-0002-2248-323X)
- Nils Welter (ORCID: https://orcid.org/0000-0001-9874-4726)
- Kathy Pritchard‐Jones (ORCID: https://orcid.org/0000-0002-2384-9475)
- Marry M. van den Heuvel‐Eibrink (ORCID: https://orcid.org/0000-0002-7760-879X)
- Reem Al‐Saadi (ORCID: https://orcid.org/0000-0002-0816-5649)
- Rhoikos Furtwängler (ORCID: https://orcid.org/0000-0002-1967-8343)
- Arnauld Verschuur (ORCID: https://orcid.org/0000-0003-1070-4442)
- Aurore Coulomb L’Herminé (ORCID: https://orcid.org/0000-0002-0945-7379)
- Jenny Wegert (ORCID: https://orcid.org/0009-0009-4505-5519)
- Manfred Gessler (ORCID: https://orcid.org/0000-0002-7915-6045)
- Richard D. Williams
- Robinson Gravier‐Dumonceau
Institutions
- University of Würzburg (DE)
- Great Ormond Street Hospital (GB)
- University Hospital of Bern (CH)
- Sorbonne Université (FR)
- Hôpital Armand-Trousseau (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Comprehensive Cancer Center Mainfranken (DE)
- Princess Máxima Center (NL)
- Genomics England (GB)
- Genomics (United Kingdom) (GB)
- University College London (GB)
- Imperial College London (GB)
- Saarland University (DE)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1002/pbc.31580
- Citations
- 3
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Children's Cancer and Leukaemia Group
- Cancer Research UK
- Deutsche Krebshilfe